Cargando…

Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification

Next generation sequencing has dramatically increased our ability to localize disease-causing variants by providing base-pair level information at costs increasingly feasible for the large sample sizes required to detect complex-trait associations. Yet, identification of causal variants within an es...

Descripción completa

Detalles Bibliográficos
Autores principales: Faye, Laura L., Machiela, Mitchell J., Kraft, Peter, Bull, Shelley B., Sun, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738448/
https://www.ncbi.nlm.nih.gov/pubmed/23950724
http://dx.doi.org/10.1371/journal.pgen.1003609
_version_ 1782476837044092928
author Faye, Laura L.
Machiela, Mitchell J.
Kraft, Peter
Bull, Shelley B.
Sun, Lei
author_facet Faye, Laura L.
Machiela, Mitchell J.
Kraft, Peter
Bull, Shelley B.
Sun, Lei
author_sort Faye, Laura L.
collection PubMed
description Next generation sequencing has dramatically increased our ability to localize disease-causing variants by providing base-pair level information at costs increasingly feasible for the large sample sizes required to detect complex-trait associations. Yet, identification of causal variants within an established region of association remains a challenge. Counter-intuitively, certain factors that increase power to detect an associated region can decrease power to localize the causal variant. First, combining GWAS with imputation or low coverage sequencing to achieve the large sample sizes required for high power can have the unintended effect of producing differential genotyping error among SNPs. This tends to bias the relative evidence for association toward better genotyped SNPs. Second, re-use of GWAS data for fine-mapping exploits previous findings to ensure genome-wide significance in GWAS-associated regions. However, using GWAS findings to inform fine-mapping analysis can bias evidence away from the causal SNP toward the tag SNP and SNPs in high LD with the tag. Together these factors can reduce power to localize the causal SNP by more than half. Other strategies commonly employed to increase power to detect association, namely increasing sample size and using higher density genotyping arrays, can, in certain common scenarios, actually exacerbate these effects and further decrease power to localize causal variants. We develop a re-ranking procedure that accounts for these adverse effects and substantially improves the accuracy of causal SNP identification, often doubling the probability that the causal SNP is top-ranked. Application to the NCI BPC3 aggressive prostate cancer GWAS with imputation meta-analysis identified a new top SNP at 2 of 3 associated loci and several additional possible causal SNPs at these loci that may have otherwise been overlooked. This method is simple to implement using R scripts provided on the author's website.
format Online
Article
Text
id pubmed-3738448
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37384482013-08-15 Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification Faye, Laura L. Machiela, Mitchell J. Kraft, Peter Bull, Shelley B. Sun, Lei PLoS Genet Research Article Next generation sequencing has dramatically increased our ability to localize disease-causing variants by providing base-pair level information at costs increasingly feasible for the large sample sizes required to detect complex-trait associations. Yet, identification of causal variants within an established region of association remains a challenge. Counter-intuitively, certain factors that increase power to detect an associated region can decrease power to localize the causal variant. First, combining GWAS with imputation or low coverage sequencing to achieve the large sample sizes required for high power can have the unintended effect of producing differential genotyping error among SNPs. This tends to bias the relative evidence for association toward better genotyped SNPs. Second, re-use of GWAS data for fine-mapping exploits previous findings to ensure genome-wide significance in GWAS-associated regions. However, using GWAS findings to inform fine-mapping analysis can bias evidence away from the causal SNP toward the tag SNP and SNPs in high LD with the tag. Together these factors can reduce power to localize the causal SNP by more than half. Other strategies commonly employed to increase power to detect association, namely increasing sample size and using higher density genotyping arrays, can, in certain common scenarios, actually exacerbate these effects and further decrease power to localize causal variants. We develop a re-ranking procedure that accounts for these adverse effects and substantially improves the accuracy of causal SNP identification, often doubling the probability that the causal SNP is top-ranked. Application to the NCI BPC3 aggressive prostate cancer GWAS with imputation meta-analysis identified a new top SNP at 2 of 3 associated loci and several additional possible causal SNPs at these loci that may have otherwise been overlooked. This method is simple to implement using R scripts provided on the author's website. Public Library of Science 2013-08-08 /pmc/articles/PMC3738448/ /pubmed/23950724 http://dx.doi.org/10.1371/journal.pgen.1003609 Text en © 2013 Faye et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Faye, Laura L.
Machiela, Mitchell J.
Kraft, Peter
Bull, Shelley B.
Sun, Lei
Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification
title Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification
title_full Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification
title_fullStr Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification
title_full_unstemmed Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification
title_short Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification
title_sort re-ranking sequencing variants in the post-gwas era for accurate causal variant identification
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738448/
https://www.ncbi.nlm.nih.gov/pubmed/23950724
http://dx.doi.org/10.1371/journal.pgen.1003609
work_keys_str_mv AT fayelaural rerankingsequencingvariantsinthepostgwaseraforaccuratecausalvariantidentification
AT machielamitchellj rerankingsequencingvariantsinthepostgwaseraforaccuratecausalvariantidentification
AT kraftpeter rerankingsequencingvariantsinthepostgwaseraforaccuratecausalvariantidentification
AT bullshelleyb rerankingsequencingvariantsinthepostgwaseraforaccuratecausalvariantidentification
AT sunlei rerankingsequencingvariantsinthepostgwaseraforaccuratecausalvariantidentification